|
|
||||||||



*
Department of Biomedical Engineering, University of Virginia Health Sciences Center, Charlottesville, VA 22908;
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westf. Wilhelms-Universität Münster, Münster, Germany; and
Cardiovascular Research Center, University of Virginia Health Sciences Center, Charlottesville, VA 22908
Intravital microscopy allows detailed analysis of leukocyte
trafficking in vivo, but fails to identify the nature of leukocytes
investigated. Here, we describe the development of a CD2-enhanced green
fluorescence protein (EGFP)-transgenic mouse to characterize lymphocyte
trafficking during inflammation in vivo. A CD2-EGFP plasmid construct
including the CD2 promoter, the EGFP transgene, and the CD2 locus
control region was injected into B6CBA/F1 pronuclei.
EGFP+ offspring were backcrossed into C57BL/6 mice for six
generations. Flow cytometry demonstrated that all peripheral blood
EGFP+ cells were positive for CD2 and negative for the
granulocyte Ag Ly 6-G (GR-1). EGFPhigh cells stained
positive for CD2, CD3, CD8, TCR
-chain, and NK1.1 but did not
express the B cell and monocyte markers CD45RA, CD19, and CD11b. In
vitro stimulation assays revealed no difference in lymphocyte
proliferation and IL-2 secretion between EGFP+ and
EGFP- mice. Intravital microscopy of untreated or
TNF-
-treated cremaster muscle venules showed EGFP+ cells
in vivo, but these cells did not roll or adhere to the vessel wall. In
cremaster muscle venules treated with both TNF-
and IFN-
,
EGFPhigh cells rolled, adhered, and transmigrated at a
rolling velocity slightly higher (11 µm/s) than that of neutrophils
(10 µm/s). Blocking
4 integrin with a mAb increased
rolling velocity to 24 µm/s. These findings show that
CD8+ T cells roll in TNF-
/IFN-
-pretreated vessels in
vivo via an
4 integrin-dependent
pathway.
This article has been cited by other articles:
![]() |
S. Yakubenia, D. Frommhold, D. Scholch, C. C. Hellbusch, C. Korner, B. Petri, C. Jones, U. Ipe, M. G. Bixel, R. Krempien, et al. Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc Blood, August 15, 2008; 112(4): 1472 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bonder, M. U. Norman, T. MacRae, P. R. Mangan, C. T. Weaver, D. C. Bullard, D.-M. McCafferty, and P. Kubes P-Selectin Can Support Both Th1 and Th2 Lymphocyte Rolling in the Intestinal Microvasculature Am. J. Pathol., December 1, 2005; 167(6): 1647 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamauchi, M. Yang, P. Jiang, N. Yamamoto, M. Xu, Y. Amoh, K. Tsuji, M. Bouvet, H. Tsuchiya, K. Tomita, et al. Real-time In vivo Dual-color Imaging of Intracapillary Cancer Cell and Nucleus Deformation and Migration Cancer Res., May 15, 2005; 65(10): 4246 - 4252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thatte, V. Dabak, M. B. Williams, T. J. Braciale, and K. Ley LFA-1 is required for retention of effector CD8 T cells in mouse lungs Blood, June 15, 2003; 101(12): 4916 - 4922. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Weninger, H. S. Carlsen, M. Goodarzi, F. Moazed, M. A. Crowley, E. S. Baekkevold, L. L. Cavanagh, and U. H. von Andrian Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis J. Immunol., May 1, 2003; 170(9): 4638 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soguero, M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model J. Virol., August 12, 2002; 76(18): 9345 - 9354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |